降价进集采的两款产品销售下跌,未进集采的一款产品销售也不太好,石药集团预计2024年归母净利润减少26%。2月25日,石药集团有限公司(石药集团,1093.HK)公告称,预计截至2024年度公司拥有人应占溢利将同比减少约26%,这一预期的减少主要是由于成药业务收入较2023年度减少约7%。收入下降与集采中标情况直接关联。公告指出,津优力(聚乙二醇化重组人粒细胞刺激因子注射液)及多美素(盐酸多柔比星...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.